v3.26.3
Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Total Hippo Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024     24,866,803        
Beginning balance at Dec. 31, 2024 $ 365.2 $ 362.1 $ 0.0 $ 1,639.7 $ (2.7) $ (1,274.9) $ 3.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (45.4) (47.7)       (47.7) 2.3
Other comprehensive income 2.1 2.1     2.1    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     290,411        
Issuance of common stock from stock plans and contingently issuable shares 1.0 1.0   1.0      
Shares withheld related to net share settlement (3.2) (3.2)   (3.2)      
Stock-based compensation expense 8.5 8.5   8.5      
Distributions to noncontrolling interests (2.5)           (2.5)
Ending balance (in shares) at Mar. 31, 2025     25,157,214        
Ending balance at Mar. 31, 2025 325.7 322.8 $ 0.0 1,646.0 (0.6) (1,322.6) 2.9
Beginning balance (in shares) at Dec. 31, 2024     24,866,803        
Beginning balance at Dec. 31, 2024 365.2 362.1 $ 0.0 1,639.7 (2.7) (1,274.9) 3.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 56.6            
Ending balance (in shares) at Sep. 30, 2025     25,337,366        
Ending balance at Sep. 30, 2025 421.5 421.5 $ 0.0 1,643.3 1.4 (1,223.2) 0.0
Beginning balance (in shares) at Mar. 31, 2025     25,157,214        
Beginning balance at Mar. 31, 2025 325.7 322.8 $ 0.0 1,646.0 (0.6) (1,322.6) 2.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 3.9 1.3       1.3 2.6
Other comprehensive income 0.7 0.7     0.7    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     385,839        
Issuance of common stock from stock plans and contingently issuable shares 1.3 1.3   1.3      
Shares withheld related to net share settlement (2.2) (2.2)   (2.2)      
Stock-based compensation expense 8.6 8.6   8.6      
Distributions to noncontrolling interests (3.9)           (3.9)
Ending balance (in shares) at Jun. 30, 2025     25,543,053        
Ending balance at Jun. 30, 2025 334.1 332.5 $ 0.0 1,653.7 0.1 (1,321.3) 1.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 98.1 98.1       98.1 0.0
Other comprehensive income 1.3 1.3     1.3    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     308,622        
Issuance of common stock from stock plans and contingently issuable shares 0.5 0.5   0.5      
Repurchase of common stock (in shares)     (514,309)        
Repurchase of common stock (14.5) (14.5)   (14.5)      
Shares withheld related to net share settlement (4.0) (4.0)   (4.0)      
Stock-based compensation expense 7.6 7.6   7.6      
Distributions to noncontrolling interests (1.6)           (1.6)
Ending balance (in shares) at Sep. 30, 2025     25,337,366        
Ending balance at Sep. 30, 2025 $ 421.5 421.5 $ 0.0 1,643.3 1.4 (1,223.2) 0.0
Beginning balance (in shares) at Dec. 31, 2025 25,699,704   25,699,704        
Beginning balance at Dec. 31, 2025 $ 436.1 436.1 $ 0.0 1,651.5 1.8 (1,217.2) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 7.1 7.1       7.1  
Other comprehensive income (2.4) (2.4)     (2.4)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     336,213        
Issuance of common stock from stock plans and contingently issuable shares 1.0 1.0   1.0      
Stock-based compensation expense 6.9 6.9   6.9      
Ending balance (in shares) at Mar. 31, 2026     26,035,917        
Ending balance at Mar. 31, 2026 $ 448.7 448.7 $ 0.0 1,659.4 (0.6) (1,210.1) 0.0
Beginning balance (in shares) at Dec. 31, 2025 25,699,704   25,699,704        
Beginning balance at Dec. 31, 2025 $ 436.1 436.1 $ 0.0 1,651.5 1.8 (1,217.2) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income $ 26.0            
Ending balance (in shares) at Sep. 30, 2026 26,621,710   26,621,710        
Ending balance at Sep. 30, 2026 $ 469.0 469.0 $ 0.0 1,674.7 (14.5) (1,191.2) 0.0
Beginning balance (in shares) at Mar. 31, 2026     26,035,917        
Beginning balance at Mar. 31, 2026 448.7 448.7 $ 0.0 1,659.4 (0.6) (1,210.1) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 10.1 10.1       10.1  
Other comprehensive income (1.4) (1.4)     (1.4)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     348,981        
Issuance of common stock from stock plans and contingently issuable shares 1.1 1.1   1.1      
Stock-based compensation expense 7.1 7.1   7.1      
Ending balance (in shares) at Jun. 30, 2026     26,384,898        
Ending balance at Jun. 30, 2026 465.6 465.6 $ 0.0 1,667.6 (2.0) (1,200.0) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 8.8 8.8       8.8  
Other comprehensive income (12.5) (12.5)     (12.5)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     236,812        
Issuance of common stock from stock plans and contingently issuable shares 0.4 0.4   0.4      
Stock-based compensation expense $ 6.7 6.7   6.7      
Ending balance (in shares) at Sep. 30, 2026 26,621,710   26,621,710        
Ending balance at Sep. 30, 2026 $ 469.0 $ 469.0 $ 0.0 $ 1,674.7 $ (14.5) $ (1,191.2) $ 0.0